Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of cyclosporine A-related single nucleotide polymorphisms on post-transplant outcomes in pediatric hematologic malignancy patients undergoing allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2025 | 40766322 | PubTator, text mining | PubMed |
| De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. | Nat Commun | 2025 | 40738904 | PubTator, text mining | PubMed |
| Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients. | Int J Mol Sci | 2025 | 40508069 | PubTator, text mining | PubMed |
| Extracellular Inosine Induces Anergy in B Cells to Alleviate Autoimmune Hepatitis. | Cell Mol Gastroenterol Hepatol | 2025 | 40409684 | PubTator, text mining | PubMed |
| Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer. | Nat Immunol | 2025 | 40355731 | PubTator, text mining | PubMed |
| Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis. | J Biol Chem | 2025 | 40316019 | PubTator, text mining | PubMed |
| Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis. | Curr Opin Hematol | 2025 | 40314242 | PubTator, text mining | PubMed |
| A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. | J Exp Clin Cancer Res | 2025 | 40275348 | PubTator, text mining | PubMed |
| A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML. | Drug Resist Updat | 2025 | 40184725 | PubTator, text mining | PubMed |
| Targeted and Untargeted Proteomics-based Comparison of Adenoviral Infected hCMEC/D3 and hBMEC as a Human Brain Endothelial Cells to Study the OATP2B1 Transporter. | Mol Neurobiol | 2025 | 40085356 | PubTator, text mining | PubMed |
| Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. | Cancers (Basel) | 2025 | 40075743 | PubTator, text mining | PubMed |
| Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review. | Pharmgenomics Pers Med | 2025 | 39968370 | PubTator, text mining | PubMed |
| Human equilibrative nucleoside transporter 1 and concentrative nucleoside transporter 1 in colorectal cancer: What do we know? A systematic review. | Histol Histopathol | 2025 | 39916554 | PubTator, text mining | PubMed |
| SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters. | Nat Commun | 2025 | 39885119 | Swiss-Prot, curated | PubMed |
| Substrate and inhibitor specificity of Plasmodium nucleoside transporters ENT1 orthologs. | J Biol Chem | 2025 | 39725030 | PubTator, text mining | PubMed |
| Deep Brain Stimulation Inhibits Epileptic Seizures via Increase of Adenosine Release and Inhibition of ENT1, CD39, and CD73 Expression. | Mol Neurobiol | 2025 | 39042219 | PubTator, text mining | PubMed |
| Exploring novel dilazep derivatives as hENT1 inhibitors and potentially covalent molecular tools. | Purinergic Signal | 2025 | 38879664 | PubTator, text mining | PubMed |
| C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. | Asia Pac J Clin Oncol | 2025 | 37415393 | PubTator, text mining | PubMed |
| Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients. | Cancers (Basel) | 2024 | 39766159 | PubTator, text mining | PubMed |
| Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief. | Nat Commun | 2024 | 39737929 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=4